Indus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.78 Cr
- Satisfied Charges ₹ 26.96 Cr
- Revenue Growth 36.08%
- Profit Growth 74.21%
- Ebitda 48.35%
- Net Worth 31.05%
- Total Assets 24.60%
About Indus Life Sciences
Indus Life Sciences Private Limited (ILSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 April 2006 and has a history of 18 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹26.78 Cr. The company has closed loans amounting to ₹26.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganapathy Jayaram, Ramachandran Baskar, Ravichandran Venkatraman, and One other member serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231TN2006PTC059530
- Company No.
059530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Indus Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurthymani  | Managing Director | 18-Apr-2006 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravichandran Venkatraman | Director | 18-Apr-2006 | Current |
| Ganapathy Jayaram | Director | 18-Apr-2006 | Current |
| Ramachandran Baskar | Director | 18-Apr-2006 | Current |
Financial Performance of Indus Life Sciences.
Indus Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 36.08% increase. The company also saw a substantial improvement in profitability, with a 74.21% increase in profit. The company's net worth Soared by an impressive increase of 31.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Life Sciences?
In 2024, Indus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bridge Green Upcycle Private LimitedKrishnamurthymani is a mutual person
Charges (Loans)
₹26.78 Cr
₹26.96 Cr
Charges Breakdown by Lending Institutions
- Others : 26.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2020 | Others | ₹26.78 Cr | Open |
| 25 Nov 2016 | Standard Chartered Bank | ₹6.60 M | Satisfied |
| 20 Dec 2014 | State Bank Of India | ₹26.30 Cr | Satisfied |
How Many Employees Work at Indus Life Sciences?
Indus Life Sciences has a workforce of 39 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.